Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updates on systemic therapy for cervical cancer.
Gopu P, Antony F, Cyriac S, Karakasis K, Oza AM. Gopu P, et al. Among authors: karakasis k. Indian J Med Res. 2021 Aug;154(2):293-302. doi: 10.4103/ijmr.IJMR_4454_20. Indian J Med Res. 2021. PMID: 35295013 Free PMC article. Review.
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.
Oza AM, Castonguay V, Tsoref D, Diaz-Padilla I, Karakasis K, Mackay H, Welch S, Weberpals J, Hoskins P, Plante M, Provencher D, Tonkin K, Covens A, Ghatage P, Gregoire J, Hirte H, Miller D, Rosen B, Maroun J, Buyse M, Coens C, Brady MF, Stuart GC. Oza AM, et al. Among authors: karakasis k. Curr Oncol. 2011 Oct;18 Suppl 2(Suppl 2):S20-7. Curr Oncol. 2011. PMID: 21969808 Free PMC article.
Outcomes and endpoints in cancer trials: bridging the divide.
Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, Kaye S, Parmar MK, Sydes MR, Tannock IF, Oza AM. Wilson MK, et al. Among authors: karakasis k. Lancet Oncol. 2015 Jan;16(1):e43-52. doi: 10.1016/S1470-2045(14)70380-8. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638556 Review.
Safety evaluation of olaparib for treating ovarian cancer.
Lheureux S, Bowering V, Karakasis K, Oza AM. Lheureux S, et al. Among authors: karakasis k. Expert Opin Drug Saf. 2015 Aug;14(8):1305-16. doi: 10.1517/14740338.2015.1045875. Epub 2015 Jun 8. Expert Opin Drug Saf. 2015. PMID: 26051946 Review.
Discrepancies in drug approvals: A global dilemma.
Wilson MK, Karakasis K, Oza AM. Wilson MK, et al. Among authors: karakasis k. Cancer. 2015 Sep 15;121(18):3360-1. doi: 10.1002/cncr.29484. Epub 2015 Jun 16. Cancer. 2015. PMID: 26079099 Free article. No abstract available.
Ovarian cancer treatment: The end of empiricism?
Lheureux S, Karakasis K, Kohn EC, Oza AM. Lheureux S, et al. Among authors: karakasis k. Cancer. 2015 Sep 15;121(18):3203-11. doi: 10.1002/cncr.29481. Epub 2015 Jun 10. Cancer. 2015. PMID: 26096019 Free PMC article. Review.
How to assess the potential interest of aspirin in ovarian cancer?
Lheureux S, Karakasis K, Oza AM. Lheureux S, et al. Among authors: karakasis k. Cancer Epidemiol. 2015 Oct;39(5):790-1. doi: 10.1016/j.canep.2015.07.002. Epub 2015 Jul 16. Cancer Epidemiol. 2015. PMID: 26189924 No abstract available.
39 results